HEATHER FEAN: Open Payments
NPI 1538379771 · SHORT HILLS, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,245 in 76 payments from 13 companies in 2025. Trend: 2023 $981 · 2024 $889 · 2025 $1,245
Food & beverage: $1,245
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $265 |
| ABBVIE INC. | 23 | $240 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $178 |
| AstraZeneca Pharmaceuticals LP | 7 | $176 |
| Lilly USA, LLC | 9 | $139 |
| Lundbeck LLC | 3 | $54 |
| Exact Sciences Corporation | 2 | $49 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $32 |
| GlaxoSmithKline, LLC. | 2 | $30 |
| Corcept Therapeutics | 1 | $22 |
Products named: Kerendia, Ozempic, VRAYLAR, FARXIGA, AIRSUPRA, MOUNJARO, JARDIANCE, REXULTI.
Industry payments across NJ — which companies pay providers there.
